In brief
The 28‑year‑old defendant, Luigi Mangione, is no longer pursuing a psychiatric defence in the state murder trial over the fatal shooting of UnitedHealthcare CEO Brian Thompson. He had previously indicated an "extreme emotional disturbance" at the time of the incident, but the attorneys reversed course just a day after notifying the judge. Dropping the defence removes the possibility of a manslaughter conviction and a lighter sentence. Mangione continues to face federal stalking charges that could carry a life‑in‑prison maximum, with a court appearance scheduled for August 11 and the state trial beginning on September 8.
Luigi Mangione, 28, accused of fatally shooting UnitedHealthcare chief executive Brian Thompson on 4 December 2024, has decided not to pursue a psychiatric defence in his state murder trial.
According to court filings, Mangione’s attorneys had told Judge Gregory Carro that they would argue he suffered from “extreme emotional disturbance” at the time of the incident. A day later, they reversed that stance and informed the court they would no longer attempt a psychiatric defence.
Had the defence been accepted, Mangione could have faced a manslaughter conviction instead of murder, which would have potentially resulted in a shorter prison term. The new position means the prosecution will likely aim for a full murder conviction with all associated penalties in play.
Mangione remains in Manhattan for a forthcoming hearing on 11 August, with the state trial set to commence on 8 September. He also faces federal stalking charges that carry a maximum sentence of life in prison.
In a related ruling, the judge determined Mangione would not face the death penalty if convicted, further shaping the trajectory of his legal proceedings.
The case continues to draw scrutiny as the defense team, prosecutors, and the courts navigate the complex legal and psychiatric elements surrounding the tragic shooting.
